Aurinia Pharmaceuticals Inc (AUPH)
Capital Expenditure
-$173.59K
TTM · Period ending: · USD
AUPH Capital Expenditure
Latest reported-$173.59Kperiod ending
Latest reported-$173.59Kperiod ending
AUPH TTM CapEx ($0.00 → -$173.59K)
TTM CapEx
High-resolution chart · PNG
AUPH capital expenditure history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Capital Expenditure (USD) |
|---|---|
| -173,585 | |
| -271,764 | |
| -249,764 | |
| -236,000 | |
| -256,000 | |
| -286,000 | |
| -281,000 | |
| -284,000 | |
| -94,000 | |
| -193,000 | |
| -690,000 | |
| -765,000 | |
| -907,677 | |
| -719,677 | |
| -289,677 | |
| -190,677 | |
| -312,000 | |
| -501,000 | |
| -1,603,000 | |
| -6,037,000 | |
| -10,157,000 | |
| -10,060,000 | |
| -9,092,000 | |
| -4,651,000 | |
| -402,000 | |
| -293,000 | |
| -100,000 | |
| -94,000 | |
| -64,000 | |
| -73,000 | |
| -75,000 | |
| -62,000 | |
| -62,000 | |
| -43,000 | |
| -25,000 | |
| -33,000 | |
| -37,000 | |
| -28,000 | |
| -25,000 | |
| -8,000 | |
| -22,000 | |
| -41,000 | |
| -50,000 | |
| -71,000 | |
| -74,000 | |
| -99,000 | |
| -90,000 | |
| -86,003 | |
| -100,870 | |
| -99,491 | |
| -104,388 | |
| -97,123 | |
| -72,432 | |
| -35,660 | |
| -38,784 | |
| -114,059 | |
| -102,677 | |
| -122,426 | |
| -1,204,041 | |
| -1,140,047 | |
| -1,168,170 | |
| -1,157,965 | |
| -84,986 | |
| -131,380 | |
| -207,824 | |
| -217,257 | |
| -232,070 | |
| -262,554 | |
| -216,407 | |
| -291,641 | |
| -336,894 | |
| -530,261 | |
| -736,312 | |
| -750,962 | |
| -867,414 | |
| -918,381 | |
| -1,244,575 | |
| -1,187,694 | |
| -1,221,688 | |
| -1,492,635 | |
| -915,480 | |
| -902,937 | |
| -730,153 | |
| -237,797 | |
| -730,753 | |
| -774,496 | |
| -870,115 | |
| -957,267 | |
| -983,567 | |
| -1,699,957 | |
| -2,260,231 | |
| -3,376,042 | |
| -4,150,538 | |
| -3,648,273 | |
| -4,624,248 | |
| -3,700,761 | |
| -2,532,188 | |
| -2,307,385 | |
| -938,124 | |
| -556,025 |